The acquisition of DreamPharma seems to be turning into a three-way battle of Kwangdong Pharmaceutical, Ahngook Pharmaceutical and Alvogen

Published: 2014-05-22 15:24:23

Updated: 2014-05-22 15:24:23

The acquisition of DreamPharma seems to be turning into a three-way battle of Kwangdong Pharmaceutical, Ahngook Pharmaceutical and Alvogen.

On May 20, the headquarter of stock market asked companies including JW Joongwae, Kwangdong Pharmaceutical and Ahngook Pharmaceutical to answer about the rumors related to the acquisition of DreamPharma.

JW Joongwae confirmed that they gave up the acquisi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.